Wells Fargo analyst Stephen Baxter downgraded Molina Healthcare (MOH) to Equal Weight from Overweight with a price target of $141, down from $208. The firm says that despite materially rebasing 2026 expectations, Molina’s guidance is dependent on “much less” acuity pressure in Medicaid and does not appear conservative. The company’s continued volatility of revenue and expense accruals “is also concerning,” the analyst tells investors in a research note. Wells views Molina’s Q4 report as “quite poor.”
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH:
- Molina Healthcare downgraded to Equal Weight from Overweight at Wells Fargo
- Molina Healthcare price target lowered to $145 from $190 at Truist
- Molina Healthcare price target lowered to $142 from $194 at JPMorgan
- Molina Healthcare’s Margins at Risk as Medicaid Rates Lag Rising Medical Costs
- Molina Healthcare price target lowered to $124 from $167 at Goldman Sachs
